{{Rsnum
|rsid=10857561
|Gene=MAPK8
|Chromosome=10
|position=49608638
|Orientation=plus
|GMAF=0.2608
|Gene_s=MAPK8
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 13.3 | 42.5 | 44.2
| HCB | 14.3 | 44.4 | 41.4
| JPT | 8.0 | 47.3 | 44.6
| YRI | 1.4 | 26.7 | 71.9
| ASW | 0.0 | 33.3 | 66.7
| CHB | 14.3 | 44.4 | 41.4
| CHD | 8.4 | 46.7 | 44.9
| GIH | 25.7 | 41.6 | 32.7
| LWK | 1.8 | 29.4 | 68.8
| MEX | 8.9 | 30.4 | 60.7
| MKK | 4.5 | 32.9 | 62.6
| TSI | 7.8 | 33.3 | 58.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=23027623
|Title=MAP kinase genes and colon and rectal cancer
|OA=1
}}

{{PMID Auto
|PMID=18036196
|Title=The G/G genotype of a single nucleotide polymorphism at -1066 of c-Jun N-terminal kinase 1 gene (MAPK8) does not affect type 2 diabetes susceptibility despite the specific binding of AP2alpha.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}